Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
0(0%)
Results Posted
38%(6 trials)

Phase Distribution

Ph phase_1
3
17%
Ph phase_3
4
22%
Ph not_applicable
2
11%
Ph phase_2
9
50%

Phase Distribution

3

Early Stage

9

Mid Stage

4

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
3(16.7%)
Phase 2Efficacy & side effects
9(50.0%)
Phase 3Large-scale testing
4(22.2%)
N/ANon-phased studies
2(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

94.1%

16 of 17 finished

Non-Completion Rate

5.9%

1 ended early

Currently Active

0

trials recruiting

Total Trials

18

all time

Status Distribution
Completed(16)
Terminated(1)
Other(1)

Detailed Status

Completed16
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (16.7%)
Phase 29 (50.0%)
Phase 34 (22.2%)
N/A2 (11.1%)

Trials by Status

withdrawn16%
completed1689%
unknown16%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT02810457Phase 3

Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer

Completed
NCT01996826Phase 1

A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

Completed
NCT01787669Phase 2

Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

Completed
NCT00557492Phase 2

Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer

Completed
NCT01072357Phase 1

Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

Completed
NCT01270542Not Applicable

Avastin for PDR (Proliferative Diabetic Retinopathy)

Completed
NCT00458315Phase 2

Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor

Withdrawn
NCT00081614Phase 2

A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma

Completed
NCT00109226Phase 2

A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

Completed
NCT00096967Phase 3

A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Completed
NCT00109057Phase 2

An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Completed
NCT00109070Phase 3

A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer

Completed
NCT01020747Phase 1

Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)

Completed
NCT00336648Phase 2

Preop Chemoradiation Resectable Pancreas

Completed
NCT00376701Phase 2

Combination Therapy for Age-Related Macular Degeneration.

Completed
NCT01422018Not Applicable

Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy

Unknown
NCT00370851Phase 3

Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial

Completed
NCT00095225Phase 2

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18